Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaBone MarrowTransplantation, HomologousAntineoplastic Combined Chemotherapy ProtocolsMelphalanBone Marrow TransplantationTransplantation ConditioningCombined Modality TherapyBone Marrow CellsTreatment OutcomeRemission InductionStem CellsSalvage TherapyDisease-Free SurvivalCyclophosphamideEtoposideHodgkin DiseaseLymphoma, Non-HodgkinBone Marrow PurgingRecurrenceCytarabineGraft vs Host DiseaseMyeloablative AgonistsCarmustineHematopoietic Stem Cell MobilizationHematopoietic Stem CellsSurvival RateThiotepaVincristineWhole-Body IrradiationHematologic NeoplasmsSurvival AnalysisLymphoma, Mantle-CellRetrospective StudiesBusulfanAmyloidosisBone and BonesDoxorubicinGraft SurvivalPrognosisAntigens, CD34DexamethasoneBoronic AcidsPyrazinesFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularAntineoplastic Agents, AlkylatingTime FactorsAutograftsLymphoma, T-Cell, PeripheralGranulocyte Colony-Stimulating FactorMesenchymal Stem Cell TransplantationAntineoplastic AgentsLiver TransplantationThalidomideIfosfamideTransplantation ChimeraLymphomaInduction ChemotherapyPrednisoneLeukapheresisLeukemia, Myeloid, AcutePodophyllotoxinNeoplasm, ResidualTissue DonorsLymphoma, Large B-Cell, DiffuseMaintenance ChemotherapyMyelodysplastic SyndromesHematopoiesisCord Blood Stem Cell TransplantationCell DifferentiationCell TransplantationLymphoma, B-CellKidney TransplantationBone Marrow DiseasesEmbryonic Stem CellsMitoxantroneIdarubicinEnteropathy-Associated T-Cell LymphomaLeukemiaHistocompatibility TestingLeukemia, Plasma CellNeoplasms, Second PrimaryLeukemia, MyeloidAntibodies, MonoclonalProspective StudiesImmunosuppressive AgentsAdult Stem CellsInfusions, SpinalCisplatinCarboplatinBlood Component RemovalMesenchymal Stromal CellsHistocompatibilityChemotherapy, Adjuvant